ea0086p109 | Neuroendocrinology and Pituitary | SFEBES2022
Bhavra Kirandeep
, Hamblin Ross
, Ayuk John
, Boelaert Kristien
, Karavitaki Niki
Introduction: TSH-secreting pituitary adenomas (TSHomas) are rare pituitary tumours treated primarily with surgery; in cases of surgical failure, somatostatin analogue (SSA) or radiotherapy are further options. SSAs are rarely used as monotherapy; if responsive and in the absence of radiotherapy, the requirement of life-long medical treatment, is unknown. Herein, we present a patient with a TSHoma who remains in remission three years after SSA withdrawal.<p class="abstext"...